Apetito, consumo de energa y eleccin de alimentos: La semaglutida, en comparacin con el placebo, redujo la ingesta de la energa de 3 comidas ad libitum (a voluntad) consecutivas en un 18-35 %
Metformin has long been used as a first-line treatment for PCOS, demonstrating effectiveness in managing symptoms like acne, excessive androgen hormones, and cardiovascular issues [12]
In the STEP trials, approximately 3% of participants reported hair loss
In clinical studies, the average weight loss was 15% and 20% with 77% of patients seeing sustained results for 2 years* *In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)